Bloqcube
Driving Clinical Trial Efficiency with a Unified Solution

Blockchain technology has gained traction as the remedy to longstanding issues of visibility, integrity, security, and speed in data management across pharmaceuticals, life sciences, and healthcare sectors. A key player addressing these challenges with its blockchain expertise is Bloqcube, an innovative clinical trials management and financial system (CTMFS) software company.

It offers a unified solution for managing clinical trial operations, featuring multiple modules linked through a blockchain engine. Its CTMFS is a fully integrated and decentralized remote trial management system that targets clinical trial operations inefficiency, data integrity, financial integration, and supply chain management issues.

Bloqcube’s cloud-based system leverages blockchain and cryptographic security capabilities to provide a seamless flow of compliant data and protection against ransomware attacks. It consolidates multiple trial functions in a single system, even if the trial is conducted across various geographies. This reduces costs, accelerates project completion, and minimizes the possibility of data tampering and fraud. Immutability of data and prevention of fabricated research enhance trust in clinical trial data.

“Our smart contract capabilities provide a more pragmatic and practical solution for accounting, budget reconciliation, and data integrity across financial operations,” says Rama Krishna Rao, CEO and founder, Bloqcube^®.

The system ensures program managers and supervisors have better governance and control over the trials. The real-time patient data and financial spending provides a continuous view of resource consumption, enabling clinical program leaders to make informed decision at the right time. Its proprietary C2TA^™ module provides real-time views of patient activity and financial data that eliminates bottlenecks and the need for labor-intensive reconciliations. It allows patients to participate anywhere, making it easier and faster to collect electronic data without any need for gathering trial subjects at a central location. The automation of the monitoring processes improves overall operational efficiency.

A study in an Indian rural area exemplifies Bloqcube’s ability to drive operational efficiency. The client was running an observational diabetes study with 850 patients and aimed to gather all the data in 12 months. Initially, Bloqcube configured the software for 150 patients, which allowed the client to complete the process in 12 days.

Eventually, the client applied the software to study the entire population and saved around 60 percent of the time.

Bloqcube aims to build a peer-to-peer mechanism that enables decentralized science. This allows for involving more participants in clinical studies, democratizing data ownership, and incentivizing individuals. The company connects clinical trial data with tokens to provide participants with the control of their data. It takes clinical trial data, links it up with a token, and allows individuals to own it as a digital asset for their life or as an inheritance. It believes the true impact of decentralized science can only be achieved through participant incentivizing. Bloqcube envisions turning participants from healthcare consumers into healthcare producers. This can address the issue of fairness and compensation for data usage, especially in developing regions, and contribute to preventive healthcare approaches.

Our smart contract capabilities provide a more pragmatic and practical solution for accounting, budget reconciliation, and data integrity across financial operations

Bloqcube is a fully validated system that conforms to the FDA's 21 CFR part 11 guidelines and all the data privacy legislation. The company aims to revalidate delivery and performance objectives in multiple scenarios to showcase the versatility of the system and the breadth and depth of its capabilities.

Further enhancing its offerings, Bloqcube released a blockchain-based supply chain solution IoT tracker for clinical trial materials. This provides information on products' location, temperature, light, shock, and humidity. In the case of a product recall, it can use this data to go with a pull-based strategy for inventory and supply chain management instead of a push-based strategy, conceptually reducing wastage in the supply chain.

Its dedication and efficiency-focused innovations resulted in Bloqcube’s nomination among the best startups by the Prix Galien Awards Committee this year. The company strives to accelerate the speed and efficiency of clinical trials to bring lifesaving medicine faster into the market